GlassScriptPhysician profile
Anthony J Kwon
NPI 1194787176
$1,855,143.81
in general payments reported to CMS, 2019-2025
20 companies · $411K in 2025
The $411K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237K · 2020: $138K · 2021: $81K · 2022: $297K · 2023: $329K · 2024: $363K · 2025: $411K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $918K · Consulting Fee: $149K · Travel and Lodging: $28K · Food and Beverage: $7,985.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $917,876.16 |
| Consulting Fee | $148,934.00 |
| Travel and Lodging | $28,065.92 |
| Food and Beverage | $7,985.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $939,395.86 | 2019-2023 | Modulus, Coroent, Alif |
| Globus Medical, INC. | $749,790.07 | 2019-2025 | Modulus, Modulus, Coroent |
| Alphatec Spine, INC | $160,474.75 | 2019-2025 | Other - Miscellaneous, Ltp, Ltx |
| Orthofix Medical, INC. | $2,712.95 | 2023-2025 | Lattus, Mariner, 7d Surgical System |
| Curiteva, INC. | $742.96 | 2023-2024 | |
| Mml US, INC. | $414.35 | 2022 | |
| Kuros Biosciences USA, INC | $381.05 | 2024-2025 | Magnetos |
| Boston Scientific Corporation | $237.50 | 2020 | |
| Sanara Medtech INC. | $199.37 | 2023 | Celleraterx |
| Medtronic USA, INC. | $195.59 | 2020 | |
| Relievant Medsystems, INC. | $153.85 | 2021 | |
| Bioventus LLC | $125.00 | 2019 | |
| Trackx Technology, INC. | $103.63 | 2023 | |
| Carlsmed, INC. | $89.46 | 2023 | Aprevo |
| Intrinsic Therapeutics | $58.08 | 2023 | Barricaid Acd (Annular Closure Device) |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carbofix Orthopedics INC | $21.48 | 2021 | |
| Stryker Corporation | $17.46 | 2021 | |
| Theragen, INC. | $16.54 | 2023 | Actastim-S |
| Depuy Synthes Sales INC. | $13.86 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.